back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-20 14:24 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,206,000
+200,000 vol $6.03 each |
600,000 | |
| Filed 2022-12-28 15:45 Tx date 2022-12-28 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$128,357
+28,000 vol $4.58 each |
169,856 | |
| Filed 2022-12-20 16:12 Tx date 2022-12-20 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$117,713
+22,000 vol $5.35 each |
141,856 | |
| Filed 2022-07-10 12:45 Tx date 2022-07-10 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,667 vol |
400,000 | |
| Filed 2022-06-29 11:53 Tx date 2022-06-29 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-3,333 vol |
100,000 | |
| Filed 2022-01-14 11:57 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
406,667 | |
| Filed 2021-08-12 16:03 Tx date 2021-08-12 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+70,000 vol |
103,333 | |
| Filed 2021-07-08 14:31 Tx date 2021-07-08 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+30,000 vol |
33,333 | |
| Filed 2021-03-30 17:58 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$636,000
+150,000 vol $4.24 each |
156,667 | |
| Filed 2020-01-06 18:58 Tx date 2020-01-02 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-996,667 vol |
3,333 | |
| Filed 2020-01-06 18:56 Tx date 2020-01-02 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,993,333 vol |
6,667 | |
| Filed 2020-01-06 18:53 Tx date 2020-01-02 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-35,836,846 vol |
119,856 | |
| Filed 2019-11-15 17:09 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2019-11-15 17:07 Tx date 2019-11-15 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-1,000,000 vol |
1,000,000 | |
| Filed 2019-11-15 15:02 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-15 15:02 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
-1,000,000 | ||
| Filed 2019-11-15 15:02 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-15 15:02 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-15 14:59 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-15 13:32 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-15 13:32 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2019-02-09 16:58 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-09 16:58 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-16 11:59 Tx date 2019-10-15 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$150,003
+2,142,900 vol $0.07 each |
35,956,702 | |
| Filed 2019-09-12 10:28 Tx date 2019-09-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$220,801
+3,154,302 vol $0.07 each |
33,813,802 | |
| Filed 2019-08-02 13:26 Tx date 2019-05-31 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+210,000 vol |
||
| Filed 2019-06-02 18:26 Tx date 2019-05-31 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+210,000 vol |
||
| Filed 2019-06-11 17:44 Tx date 2019-06-11 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+424,000 vol |
30,869,500 | |
| Filed 2019-06-10 16:35 Tx date 2019-06-10 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+576,000 vol |
30,445,500 | |
| Filed 2019-06-10 09:23 Tx date 2019-06-05 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+409,000 vol |
29,869,500 | |
| Filed 2019-06-05 09:03 Tx date 2019-06-04 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+286,000 vol |
29,460,500 | |
| Filed 2019-06-04 07:18 Tx date 2019-06-03 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+305,000 vol |
29,174,500 | |
| Filed 2019-06-02 18:26 Tx date 2019-05-31 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+210,000 vol |
28,869,500 | |
| Filed 2019-05-21 13:29 Tx date 2019-05-17 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+216,000 vol |
28,659,500 | |
| Filed 2019-05-16 17:04 Tx date 2019-05-16 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+332,000 vol |
28,443,500 | |
| Filed 2019-05-16 17:03 Tx date 2019-05-15 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+115,000 vol |
28,111,500 | |
| Filed 2019-05-14 16:37 Tx date 2019-05-14 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+20,000 vol |
27,996,500 | |
| Filed 2019-05-13 16:12 Tx date 2019-05-13 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,231,000 vol |
27,976,500 | |
| Filed 2019-05-09 17:58 Tx date 2019-05-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+5,000 vol |
26,745,500 | |
| Filed 2019-04-18 12:14 Tx date 2019-04-18 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+3,000,000 vol |
26,740,500 | |
| Filed 2019-04-17 19:46 Tx date 2019-04-17 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+200,000 vol |
23,740,500 | |
| Filed 2019-04-12 12:44 Tx date 2019-04-12 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+250,000 vol $0.11 each |
23,540,500 | |
| Filed 2019-03-25 Tx date 2019-03-25 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$500,000
+5,000,000 vol $0.10 each |
23,290,500 | |
| Filed 2019-03-07 Tx date 2019-03-05 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+150,000 vol |
18,220,500 | |
| Filed 2019-03-07 Tx date 2019-03-06 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+70,000 vol |
18,290,500 | |
| Filed 2019-02-12 Tx date 2019-02-12 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,000,000 vol |
18,070,500 | |
| Filed 2019-02-09 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2019-02-09 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
2,200,000 | ||
| Filed 2019-02-09 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
16,070,500 |